Chair, President and CEO Sharon Mates sold $5.4M of Intra-Cellular Therapies, Inc.

Sold$5,394,065

$53.94Price

100,000Shares

−9%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Mon, Sep 18. Filed Tue, Sep 19, 8:40 PM ET, after the close. Not investment advice.